Utilization and treatment costs of tumor necrosis factor inhibitors after the introduction of biosimilar infliximab in the United States
| Image |  |
|---|---|
| Description | scientific article published on 13 January 2020 |
| Author/s | |
| Publication date | January 13, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |